P160032/S017: Lifeline VIEW 2, Lifeline VIEW 2 AUTO and Lifeline ECG 2 AED
FDA’s recorded scope: approval for a labeling change to include an optional maintenance option to continually monitor the readiness of the DDU-29XX series AEDs
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 4 FDA records to the applicant name Defibtech, LLC. 4 entries are PMA supplements. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 16, 2026 to Aug 25, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MKJ appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P160032, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 741 Boston Post Rd., Suite 201, Guilford, CT, 06437. Recorded on P160032/S017, decision dated Aug 25, 2026.
Automated External Defibrillators (Non-Wearable).
FDA’s recorded scope: approval for a labeling change to include an optional maintenance option to continually monitor the readiness of the DDU-29XX series AEDs
FDA’s recorded scope: extending the Defibtech DDU-2000 series AED to the new VIEW 2 series which include models: Lifeline VIEW 2 model DDU-2950, Lifeline VIEW 2 AUTO DDU-2955, Lifeline ECG 2 DDU-2960, and the Universal Pads accessory model DDP-2004.
FDA’s recorded scope: approval for a labeling change to include an optional maintenance option to continually monitor the readiness of the DDU-2XXX series AEDs
FDA’s recorded scope: approval for manufacturing updates and to remove redundant steps
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 6 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 6 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Defibtech, LLC | Class II | May 7, 2025 | FDA | |
| Defibtech, LLC | Class II | May 7, 2025 | FDA | |
| Defibtech, LLC | Class II | May 7, 2025 | FDA | |
| Defibtech, LLC | Class II | May 7, 2025 | FDA | |
| Defibtech, LLC | Class II | May 7, 2025 | FDA | |
| Defibtech, LLC | Class II | Dec 4, 2024 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 20, 2026.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Defibtech, LLC | PMA supplement | Aug 25, 2026 | FDA | |
| Defibtech, LLC | PMA supplement | Jul 24, 2026 | FDA | |
| Defibtech, LLC | PMA supplement | Jun 25, 2026 | FDA | |
| Defibtech, LLC | PMA supplement | Jun 16, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.